Treo Ventures

Strategic Healthcare Investment Partners (S.H.I.P.) is now Treo Ventures. We focus on medical device and digital health innovation with significant clinical impact. We invest through our offices in Silicon Valley, USA, and Dublin, Ireland. Our investment criteria are based on the following guiding principles: Therapeutic Areas: We focus on large therapeutic areas including but not limited to: Cardiovascular, Neurovascular, Respiratory, Ophthalmology, Orthopedics and Spine, Metabolic: Obesity and Diabetes, ENT. We are also interested in neuromodulation-based therapies targeting multiple disease states. Stage: We invest in both early (companies raising their first or second venture financing rounds, with some proof of concept), and later-stage companies (companies that have strong clinical data and are seeking regulatory approval). Technology Profile: We are interested in platform technologies. We invest in companies with strong intellectual property positions allowing these companies to maximize the value of their technology platform. A unique and proprietary product pipeline is key.